FDMT vs NKE · rev $6.8M vs P/E 35, rev $46.40B
4D Molecular Therapeutics Inc (FDMT) versus Nike Inc (NKE) — a side-by-side from cached financials, not a winner call.
4D Molecular Therapeutics Inc (FDMT) is a biotechnology company listed on US.
Nike Inc (NKE) is a footwear & accessories company listed on US. It is led by John Donahoe.
Latest reported FDMT revenue for 2026-06-30 was $6.8M. Net income was -$141.7M. FDMT currently screens at market cap $518.1M.
Latest reported NKE revenue for 2026-05-31 was $46.40B. Net income was $3.11B. Revenue was up 0.2% from 2025-05-31 to 2026-05-31. NKE currently screens at market cap $110.14B and trailing P/E 34.6.
FDMT currently screens at market cap $518.1M. NKE currently screens at market cap $110.14B and trailing P/E 34.6.
Not investment advice. Open the FDMT and NKE stock pages for the full models.
Not investment advice.